Trial intelligence / Profile preview

Topical Diclofenac vs. Oral Ibuprofen for Musculoskeletal Pain in Children

NCT07145645Phase 3Recruiting

Sponsor
University of Calgary
Start
Apr 2026
Primary completion
Sep 2027
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Musculoskeletal pain comparing Topical Diclofenac + Oral Placebo with Oral Ibuprofen + Topical Placebo (2 arms). Primary endpoint: Feasibility of a large trial at 18 months. Started Apr 2026; status: recruiting.

02

Drugs

diclofenac
03

Conditions

Musculoskeletal pain

Beyond the preview

Go deeper on NCT07145645.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07145645.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call